During the past decade, UAMS Psychiatric Research Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UAMS Psychiatric Research Institute" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator and "Baylor College of Medicine" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "UAMS Psychiatric Research Institute" are "Methamphetamine or Cocaine Dependence" (1 trials) and "Opioid Dependence" (1 trials). Many other conditions were trialed in "UAMS Psychiatric Research Institute" in a lesser frequency.

Most popular intervention types in "UAMS Psychiatric Research Institute" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Doxazosin extended release" (1 trials), "Isradipine" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "UAMS Psychiatric Research Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UAMS Psychiatric Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in UAMS Psychiatric Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UAMS Psychiatric Research Institute, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".